Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia

Blood Cancer J. 2024 Jan 25;14(1):22. doi: 10.1038/s41408-023-00940-5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*